1. 1) Tanihara S, Suzuki S. Estimation of the incidence of MRSA patients: evaluation of a surveillance system using health insurance claim data. Epidemiol. Infect., 144, 2260–2267 (2016).
2. 2) WHO. “Global action plan on antimicrobial resistance.”: ‹https://www.who.int/antimicrobial-resistance/global-action-plan/en/›, accessed 24 May, 2019.
3. 3) Ministry of Health. Labor and Welfare. “National Action Plan on Antimicrobial Resistance.”: ‹https://www.mhlw.go.jp/file/06-Seisakujouhou-10900000-Kenkoukyoku/0000138942.pdf›, accessed 24 May, 2019.
4. 4) Yamasaki D, Tanabe M, Muraki Y, Kato G, Ohmagari N, Yagi T. The first report of Japanese antimicrobial use measured by national database based on health insurance claims data (2011–2013): comparison with sales data, and trend analysis stratified by antimicrobial category and age group. Infection, 46, 207–214 (2018).
5. 5) Ministry of Health. Labor and Welfare. “Japan Nosocomial Infections Surveillance.”: ‹https://janis.mhlw.go.jp/english/index.asp›, accessed 24 May, 2019.